COY PAPACHEK

• Contract employee responsible for sales and surgical support for Paragon 28 Foot & Ankle products
• Target specialties include: Podiatry and Foot & Ankle Orthopedic Surgeons
• Provide surgical support for all of Paragon 28’s hardware and biologic systems in the operating room
• Bunions, hammertoes, bone osteotomies, ankle fractures, and fusions of forefoot, midfoot and hindfoot
• Maintain access with administrators and operating room personnel at regional hospitals and surgery centers

Responsible for promotion and clinical support of the ENT product line

· Target specialties included: Otolaryngology, General Surgery and Endocrine Surgery

· Provided clinical support to over 30 cases for surgeons in the OR by assisting in the preservation of patient nerve function

o Surgeries included: Thyroidectomy, Parathyroid, Parotidectomy, Mastoidectomy, Neck Dissections, Cochlear Implants, Acoustic Neuromas and Hypoglossal Implant by Inspire

· Generated $26,225 in disposable revenue since completion of clinical training in September

• Responsible for promoting and distributing Orthofix Bone Growth Therapy Products to providers and patients in New Mexico
• Target providers who specialize in fracture management and spinal fusion procedures
• Generated $143,791.60 year-to-date revenue (143.79% to quota) in a territory with zero revenue in the past three years
• Second in region in July with 254% month-to-date revenue
• Led region in August with 179% month-to-date revenue
• Generated $16,393.34 of revenue in first two months promoting Spinal Stimulation products
• 11,043.23 of revenue in first month (November)

• Drove sales of chronic care portfolio of products for diabetes, insomnia, respiratory, and specialty antibiotic markets
• Called on primary care, internal medicine, podiatry, dermatology, infectious disease, and psychiatry across the Grand Forks territory
• Increased Januvia sales objective from 105% to 108% in 2018 and was recognized as 3rd in the nation on The Chronic Care Leaderboard in November 2018 with 109%
• Maintained highest DPP-4 in class Januvia share nationwide; increased share from 86% in October 2018 to 92% in July 2019
• Led successful launch of Steglatro across the Grand Forks territory; boosted share from 0.84% to 2.08% from May to October 2019 within SGLT2i market
• Led the nation with a 4.04% share change in Steglatro rolling 4-week new prescription data in September 2019
• Ranked #2 in region for Sivextro launch sales and led the regional specialty antibiotic market with a 12.50% target customer reach in June 2019
• Boosted Belsomra sales objective from 82% to 133% in 3 months; achieved 12th highest sales objective in nation
• Recognized in Top 10 Nationwide for Belsomra on The Chronic Care Leaderboard in January 2019 (133% to sales objective) and February 2019 (115% to sales objective)

• Delivered support to primary healthcare providers by rooming patients, taking vital signs, reviewing allergies and medications, and asking pertinent medical questions to better facilitate overall patient care
• Scheduled patient appointments, handled sensitive patient information with discretion, and recorded important details and information for providers
• Performed EKGs, assisted with aseptic procedures, and escorted patients to and from diagnostic scans